You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

631 Results
Drug
Other Name(s): Taxol®
Nov 2024
Drug
Other Name(s): Camptosar®
Sep 2025
Drug
Other Name(s): Caelyx®
Sep 2025
Drug
Other Name(s): Ifex® (multiple brands available)
Aug 2016
Drug
Other Name(s): Perjeta®
Sep 2022
Drug
Other Name(s): Pomalyst®
Apr 2025
Drug
Other Name(s): Imbruvica®
Jan 2026
Drug
Other Name(s): Zydelig™
Feb 2022
Drug
Other Name(s): Ibrance™
Oct 2025
Drug
Other Name(s): Ninlaro™
Jun 2019
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Intent: Adjuvant
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Oct 2024
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Intent: Palliative
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Oct 2024

Pages